Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network-The VISAGE Study.
Irit NachtigallStefan KwastSven HohensteinSebastian KönigPhi Long DangJohannes LeinerNicola GiesenBenjamin Thomas SchleenvoigtMarzia BonsignoreAndreas BollmannRalf KuhlenFungwe JahPublished in: Vaccines (2024)
Our findings highlight the vulnerability of IC patients to severe COVID-19. The persistently high prevalence of severe outcomes in these patients in the Omicron era emphasizes the necessity for continuous in-hospital risk assessment and monitoring of IC patients.
Keyphrases
- end stage renal disease
- sars cov
- ejection fraction
- chronic kidney disease
- risk assessment
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- type diabetes
- emergency department
- coronavirus disease
- adipose tissue
- patient reported outcomes
- metabolic syndrome
- intensive care unit
- weight loss
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- mechanical ventilation